Abbott Named One of the Top 10 Companies in Calvert Diversity Survey
Abbott (NYSE: ABT) has been named one of the Top 10 companies for diversity in a new survey conducted by Calvert Group.
Abbott (NYSE: ABT) has been named one of the Top 10 companies for diversity in a new survey conducted by Calvert Group. The survey reviewed the diversity programs, policies and performance of all companies in the Standard & Poor's 100 Index (S&P 100). Abbott received a score of 90 out of 100, which was significantly higher than the average scores of 72 for its industry sector and 68.5 for all S&P 100 companies.
In addition to being included on the Calvert survey, Abbott was named to DiversityInc magazine's 2010 list of the Top 50 Companies for Diversity, and to Hispanic Business magazine's Diversity Elite 60 Top Companies for Hispanics earlier in 2010. It was the seventh year Abbott has been included on the DiversityInc list, and the fourth year the company has been included on the Hispanic Business list. The company also was recently named one of the 100 Best Companies by Working Mother magazine; it was the tenth consecutive year the company has been included o
Related News
-
News Women in Pharma: CPHI India – India’s Pharmaceutical Industry and Gender Inclusion Challenges
India’s pharmaceutical industry has emerged as a significant player in the global market, valued at USD 50 billion in FY 2023-2024, according to Frost & Sullivan’s analysis. This sector encompasses a diverse portfolio, including drugs, vacc... -
News Women in Pharma: Advancing Women's Health
Discover the latest innovations in technologies and therapeutics that are revolutionising women's health in our latest CPHI Online Women in Pharma infographic.
-
News Women in Pharma: Bridging Science, Strategy, and Equity in Chemicals and Pharma
Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive. -
News Women in Pharma: The Final Chapter of 2025
Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and ... -
News A Day in the Life of a Senior Director at Boehringer Ingelheim
In our Day in the Life of series we love getting to know the people at the heart of pharma. In this latest interview we speak to Sanobar Syed, Senior Director at Boehringer Ingelheim, about her career and what she feels is most important for the f... -
News Women in Pharma: Revolutionising menstrual care with medical devices
Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive. -
News Women in Pharma: Quality leadership, quality services
Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive. -
News CPHI Podcast Series: Achieving global health equity through innovation
In the latest episode Lucy Chard engages in a compelling conversation with Dr Lengwe Sinkala, a seasoned clinician and Human Factors and User Experience Consultant at ClariMed.